Biomarkers of Histone Deacetylase Inhibitor Activity in a Phase 1 Combined-Modality Study with Radiotherapy

BACKGROUND: Following the demonstration that histone deacetylase inhibitors enhanced experimental radiation-induced clonogenic suppression, the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study, combining fractionated radiotherapy with daily vorinostat for pelvic carcinoma, was designed to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ree, Anne Hansen, Saelen, Marie Grøn, Kalanxhi, Erta, Østensen, Ingrid H. G., Schee, Kristina, Røe, Kathrine, Abrahamsen, Torveig Weum, Dueland, Svein, Flatmark, Kjersti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934935/
https://www.ncbi.nlm.nih.gov/pubmed/24587009
http://dx.doi.org/10.1371/journal.pone.0089750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934935/
https://www.ncbi.nlm.nih.gov/pubmed/24587009
http://dx.doi.org/10.1371/journal.pone.0089750

Ejemplares similares